CBP

DHS does not have a unified approach for procuring and using handheld chemical identification devices despite the widespread use of these devices across multiple components.  We recommended DHS establish a process to coordinate joint needs across components and maximize savings from strategic sourcing opportunities.  We made two recommendations that should help improve unity of effort in procuring and using handheld chemical identification devices.  DHS concurred with recommendation 1 but did not concur with recommendation 2.

Between 2011 and 2018, U.S. Customs and Border Protection (CBP) processed an average of $896 million in drawback claims annually; however, a lack of internal controls could affect the validity and accuracy of the drawback claims amount.  This occurred, in part, because CBP did not address internal control deficiencies over drawback claims.  The Department of Homeland Security Fiscal Year 2018 Independent Auditor’s Report on Financial Statements and Internal Control over Financial Reporting identified reoccurring CBP internal control deficiencies over drawback claims.  CBP has outlined plans to correct these deficiencies by implementing an updated data processing system and revising legislative procedures.  Without correcting these repeated control deficiencies, CBP cannot determine drawback claims’ validity and accuracy.  These corrective actions are ongoing; therefore, we could not verify during our audit whether CBP remedied the identified internal control deficiencies. Our report contains no recommendations.  

DHS did not have the Information Technology (IT) system functionality needed to track separated migrant families during the execution of Zero Tolerance.  U.S. Customs and Border Protection (CBP) adopted various ad hoc methods to record and track family separations, but this practice introduced widespread errors.  These conditions persisted because CBP did not address known IT deficiencies before the Zero Tolerance Policy was implemented in May 2018.  DHS also did not provide adequate guidance to personnel responsible for executing the policy.  Because of the IT deficiencies, we could not confirm the total number of families DHS separated during the Zero Tolerance period.  DHS estimated Border Patrol agents separated 3,014 children from their families while the policy was in place.  DHS also estimated it completed 2,155 reunifications, although this effort continued on for seven months beyond the July 2018 deadline for reunifying children with their parents.  However, we conducted a review of DHS data during the Zero Tolerance period and identified 136 children with potential family relationships that were not accurately recorded by CBP.  In a broader analysis of DHS data between the dates of October 1, 2017 to February 14, 2019, we identified an additional 1,233 children with potential family relationships not accurately recorded by CBP.  Without a reliable accounting of all family relationships, we could not validate the total number of separations, or the completion of reunifications.  Although DHS spent thousands of hours and more than $1 million in overtime costs, it did not achieve the original goal of deterring “Catch-and-Release” through the Zero Tolerance Policy.  Moreover, the surge in apprehended families during this time period resulted in children being held in CBP facilities beyond the 72-hour legal limit.  The Department concurred with all five report recommendations.

U.S. Customs and Border Protection (CBP) plays a critical role in the Nation’s efforts to interdict dangerous substances and prohibited items at U.S. ports of entry and keep these materials from harming the American public. An important part of CBP’s mission is preventing foreign countries from importing illegal drugs such as opioids into the U.S. CBP is experiencing a rise in seizures of synthetic opioids such as fentanyl that upon exposure can kill in minutes.  CBP’s Office of Field Operations (OFO) Fines Penalties and Forfeitures Division stores, manages, and disposes seized property, including illicit drugs such as fentanyl.  During our ongoing audit of CBP’s storage of seized drugs at permanent drug vaults we visited, we determined that CBP does not adequately protect its staff from the dangers of powerful synthetic opioids.  Specifically, CBP has not always made medications designed to treat narcotic overdose available in case of accidental exposure.  This occurred because CBP lacks an official policy requiring standard workplace practices for handling fentanyl and safeguarding personnel against exposure.  In addition, CBP does not require mandatory training for its staff to provide an understanding of the hazards of fentanyl and methods to combat accidental exposure.  As a result, CBP staff is at increased risk of injury or death in case of exposure.  We made one recommendation to help CBP provide its components with guidance, knowledge, and tools to handle and reverse overdoses from fentanyl and other opioids.